Frontlight ResearchEarly access
Obesity trials in Sweden
35 of 44 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 1Not yet taking people in SwedenA randomized, placebo-controlled, single-blind phase 1 trial to evaluate safety, pharmacokinetics and pharmacodynamics of subcutaneously administered RBD3133 in healthy participants with overweight/obesity
- Where
- Uppsala
- Age
- 18 years to 64 years
- People
- 80
- Run by
- Ribocure Pharmaceuticals AB
See details and how to join2026-525607-27-00 - Phase 3Taking peopleMaridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity (MARITIME-HF)
- Where
- Danderyd, Falun, Goteborg, Lund, Norrkoping, Solna, Stockholm
- Age
- 18 years and over
- People
- 2,787 worldwide
- Run by
- Amgen Inc.
See details and how to join2024-516654-22-00 - No phaseTaking peopleHYPERtension Reduction Through WALKing Stairs Versus Brisk Walking
- Where
- Stockholm
- Age
- 35 years and over
- People
- 450
- Run by
- Karolinska Institutet
See details and how to joinNCT06952348 - Phase 3Taking peopleA Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Where
- Linkoping, Lund, Moelndal, Orebro, Stockholm
- Age
- 18 years and over
- People
- 500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07776509 · EU 2025-523295-23-00 - No phaseTaking peoplePreserving Muscle Mass During Incretin-Induced Weight Loss
- Where
- Stockholm
- Age
- 18 years to 64 years
- People
- 20
- Run by
- Karolinska Institutet
See details and how to joinNCT07761923 - Phase 3Taking peopleMaridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Where
- Falun, Gothenburg, Helsingborg, Lund, Norrköping, Solna, Stockholm
- Age
- 18 years to 99 years
- People
- 5,056 worldwide
- Run by
- Amgen
See details and how to joinNCT07037459 - Phase 3Not yet taking people in SwedenA Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Established Cardiovascular Disease
- Where
- Gothenburg, Orebro, Solna, Stockholm, Uppsala
- Age
- 40 years and over
- People
- 2,500 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07843472 · EU 2026-526190-41-00 - Phase 3WithdrawnA Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
- Where
- Umea, Uppsala
- Age
- 8 years to 18 years
- People
- 460 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07253285 · EU 2023-509176-42-00 - No phaseTaking peopleThe Evira Study: Additional Support During Obesity Treatment
- Where
- Linköping, Sollefteå, Ystad
- Age
- 12 years to 17 years
- People
- 40
- Run by
- Karolinska Institutet
See details and how to joinNCT06836284 - No phaseTaking peopleMetabolic Effects of Short-term Ultra-processed Food Intake (MEST-UPF)
- Where
- Gothenburg
- Age
- 18 years to 50 years
- People
- 24
- Run by
- Göteborg University
See details and how to joinNCT07213245 - Phase 3Active, not recruitingResearch Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
- Where
- Moelndal, Orebro, Solna
- Age
- 18 years and over
- People
- 450 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07770841 · EU 2025-524626-18-00 - Phase 3Not yet taking people in SwedenLifestyle Changes, Mushroom Supplementation, and Bupropion to Reduce Adiposity and Cardiometabolic Risk
- Where
- Uppsala, Vaenersborg
- Age
- 18 years to 55 years
- People
- 250
- Run by
- Uppsala University
See details and how to joinNCT07806279 · EU 2026-527136-13-00 - Phase 3Active, not recruitingA Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight
- Where
- Lund, Molndal, Orebro, Rättvik
- Age
- 18 years and over
- People
- 285 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07745504 · EU 2025-524249-29-00 - Phase 1/2Not yet taking people in SwedenA two-part, randomised, double-blind, placebo-controlled, parallel-group, 12 week trial investigating the safety, tolerability, pharmacokinetics and efficacy of XEN-D0501 in obese participants.
- Where
- Moelndal, Uppsala
- Age
- 18 years and over
- People
- 46
- Run by
- Pila Pharma AB
See details and how to join2026-525869-42-00 - No phaseTaking peopleThe PreEclampsia Postpartum Prevention Trial
- Where
- Stockholm
- Age
- 18 years and over
- People
- 356
- Run by
- Karolinska Institutet
See details and how to joinNCT07199283 - Phase 4Not yet taking people in SwedenWaiting on Atrial Fibrillation Intervention Therapy (WAIT) Study
- Where
- Huddinge
- Age
- 18 years and over
- People
- 200
- Run by
- Emma Svennberg
See details and how to joinNCT07275697 · EU 2025-524182-25-00 - Phase 4Not yet taking people in SwedenFibrosis Lessens After Metabolic Surgery
- Where
- Linköping, Örebro
- Age
- 18 years to 75 years
- People
- 120 worldwide
- Run by
- The Cleveland Clinic
See details and how to joinNCT06374875 - Phase 1Not yet taking people in SwedenA Study of Eloralintide (LY3841136) in Participants With Overweight or Obesity
- Where
- Moelndal
- Age
- 18 years to 70 years
- People
- 115 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07665879 · EU 2025-523873-41-00 - Phase 4Taking peopleEvaluation of Influenza Vaccine Immune Response in Obesity (VaccObFlu)
- Where
- Stockholm
- Age
- 18 years to 64 years
- People
- 120
- Run by
- Region Stockholm – SLSO
See details and how to join2025-522698-13-00 - No phaseTaking peopleThe eHealth Diabetes Remission Trial
- Where
- Jönköping, Örnsköldsvik, Umeå
- Age
- 20 years to 70 years
- People
- 106
- Run by
- Umeå University
See details and how to joinNCT05491005 - No phaseNot yet taking people in SwedenAI-INFORMED PEER-MENTORING BEHAVIORAL INTERVENTION FOR OBESITY AND CARDIOVASCULAR DISEASE PRIMARY PREVENTION IN YOUTH
- Where
- Luleå
- Age
- 12 years to 25 years
- People
- 840 worldwide
- Run by
- Aikaterini Karaivazoglou
See details and how to joinNCT07505459 - No phaseTaking peopleNutrition Care in Patients Living With Chronic Pain
- Where
- Linköping
- Age
- 18 years and over
- People
- 200
- Run by
- Linkoeping University
See details and how to joinNCT06277232 - Phase 4Taking peopleEffects of an Opioid Free/Sparing Care Pathway for Patients Undergoing Obesity Surgery
- Where
- Gothenburg, Orebro
- Age
- 18 years and over
- People
- 220
- Run by
- Göteborg University
See details and how to joinNCT03756961 · EU 2023-505934-86-00 - No phaseCompletedA Multicenter Study for Evaluating a Digital Support System in Childhood Obesity Treatment
- Where
- Kalmar
- Age
- 4 years to 17 years
- People
- 680 worldwide
- Run by
- Karolinska Institutet
See details and how to joinNCT04917601 - No phaseTaking peopleEatit's Obesity Intervention: Effects on Weight, Eating Habits and Health
- Where
- Stockholm
- Age
- 18 years and over
- People
- 93
- Run by
- Eatit AB
See details and how to joinNCT07183228